Medipharm Labs Correlations
MEDIF Stock | USD 0.05 0 4.00% |
The current 90-days correlation between Medipharm Labs Corp and Green Cures Botanical is 0.07 (i.e., Significant diversification). The correlation of Medipharm Labs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Medipharm Labs Correlation With Market
Significant diversification
The correlation between Medipharm Labs Corp and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Medipharm Labs Corp and DJI in the same portfolio, assuming nothing else is changed.
Medipharm |
The ability to find closely correlated positions to Medipharm Labs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medipharm Labs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medipharm Labs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medipharm Labs Corp to buy it.
Moving against Medipharm OTC Stock
0.61 | EPGG | Empire Global Gaming | PairCorr |
0.43 | MKKGY | Merck KGaA ADR | PairCorr |
0.43 | MKGAF | MERCK Kommanditgesells | PairCorr |
0.42 | TAK | Takeda Pharmaceutical | PairCorr |
0.37 | HLN | Haleon plc | PairCorr |
0.36 | TPDDF | Talon Energy | PairCorr |
0.35 | HLNCF | Haleon plc | PairCorr |
0.48 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.36 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
0.34 | KO | Coca Cola Sell-off Trend | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Medipharm OTC Stock performing well and Medipharm Labs OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Medipharm Labs' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
GRCU | 38.25 | 10.27 | 0.19 | (2.74) | 26.93 | 100.00 | 150.00 | |||
CNNA | 7.00 | (0.05) | 0.01 | 0.10 | 10.36 | 20.00 | 89.44 | |||
RMRK | 8.78 | 1.89 | 0.04 | (0.18) | 9.96 | 33.33 | 58.33 | |||
GXXY | 4.06 | (0.73) | 0.00 | (2.46) | 0.00 | 12.97 | 67.08 | |||
GNMLF | 2.13 | 0.33 | 0.00 | 0.34 | 0.00 | 10.31 | 41.89 | |||
CVGRF | 3.89 | 1.37 | 0.00 | (1.05) | 0.00 | 0.00 | 95.65 | |||
LRSV | 7.19 | 0.43 | 0.00 | 0.23 | 0.00 | 0.00 | 150.00 | |||
GCAN | 10.06 | (0.31) | 0.00 | 0.04 | 10.92 | 25.00 | 68.57 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Medipharm Labs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
All Next | Launch Module |
Medipharm Labs Corporate Management
Elected by the shareholders, the Medipharm Labs' board of directors comprises two types of representatives: Medipharm Labs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medipharm. The board's role is to monitor Medipharm Labs' management team and ensure that shareholders' interests are well served. Medipharm Labs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medipharm Labs' outside directors are responsible for providing unbiased perspectives on the board's policies.
Greg Hunter | Chief Officer | Profile | |
Saravan Subramaniam | VP Chain | Profile | |
Nigel Dewsbury | Head Quality | Profile | |
Geoffrey Marr | Exec Counsel | Profile | |
Patrick McCutcheon | Founder | Profile | |
Brett Moon | VP Sales | Profile |